Nav: Home

Preclinical characterization of therapeutic antibodies

March 12, 2018

Even though the Shh pathway is mainly quiescent in adults, the safety of Shh-targeting with therapeutic antibodies was questioned initially because not only does the N-terminus of the Shh protein play an important role in embryonic development, but Shh also plays a poorly understood role in tissue homeostasis and repair in adults.

Furthermore, the research team previously showed that Shh+ cells expressing the full-length protein appeared to provide a signal for proliferation, migration and chemotherapy-resistance properties, making functional targeting of full-length Shh by the use of C-terminus anti-Shh antibodies an attractive therapeutic strategy.

Ex vivo analyses of A549 xenograft tumors from mice treated with the C-terminus Shh antibody Ab 1C11-2G4 provided further support that Shh signal transduction is modestly down-regulated after treatment, as evidenced by suppressed transcript and protein levels of Shh downstream target GLI. Activation of the pathway occurs when Shh binds to its receptor Patched but signaling is inhibited in a small population of cells if full-length Shh binds instead to the blocking antibody 2G4, a potential therapeutic, so that the protein cannot transmit downstream signals.

Another reason for the modest efficacy the research team observed could be that the antibody also binds cleaved C-terminus Shh produced by a majority of the cells, which has no known Shh signaling function, and which may deplete the amount of antibody available for therapeutic binding to cell-surface expressed full-length Shh.

The researchers said "Administration of Ab 1C11-2G4 not only reduced cell viability in 7 cancer cell lines but also significantly inhibited tumor growth in a xenograft model of A549 lung cancer cells."

When ectopically expressed, Shh triggers tumor formation in preclinical models, lending credence to the idea that ligand-dependent Shh pathway activation promotes tumor initiation and progression.

Targeting ligand-dependent Shh signaling with Smoothened antagonists or Shh neutralizing antibodies inhibits the growth of several tumor cell lines in vitro and in vivo.

While blocking the Shh pathway is an attractive anti-cancer strategy, no therapeutic antibody raised against the carboxy -terminal of the Shh protein has been described.

The researchers recently reported the presence of uncleaved, membrane-bound, full-length Shh on fresh primary lung tumors collected from patients and in cancer cell lines and have reported initial validation of this full-length protein as a novel marker of cancer stem cells (CSC) in NSCLC. These findings led them to hypothesize that antibodies generated against the C-terminus Shh epitope can bind and neutralize full-length Shh found exclusively on the CSC population, while leaving the cleaved N-terminus Shh, important for physiologic Shh signaling, unperturbed
-end-
Full text - http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=view&path%5B%5D=24510&path%5B%5D=76946

Correspondence to -

Bhairavi Tolani
email: Bhairavi.Tolani@ucsf.edu

David M. Jablons
email: David.Jablons@ucsf.edu

About Oncotarget

Oncotarget is twice-weekly, peer-reviewed, open access biomedical journal covering research on all aspects of oncology and publishing sub-sections on topics beyond oncology such as Aging, Immunology and Microbiology, Autophagy, Pathology and Chromosomes and more. Oncotarget is published by Rapamycin Press, the publishing division of Impact Journals LLC.

Rapamycin Press

Related Protein Articles:

Hi-res view of protein complex shows how it breaks up protein tangles
A new, high-resolution view of the structure of Hsp104 (heat shock protein 104), a natural yeast protein nanomachine with six subunits, may show news ways to dismantle harmful protein clumps in disease.
Breaking the protein-DNA bond
A new Northwestern University study finds that unbound proteins in a cell break up protein-DNA bonds as they compete for the single-binding site.
FASEB Science Research Conference: Protein Kinases and Protein Phosphorylation
This conference focuses on the biology of protein kinases and phosphorylation signaling.
Largest resource of human protein-protein interactions can help interpret genomic data
An international research team has developed the largest database of protein-to-protein interaction networks, a resource that can illuminate how numerous disease-associated genes contribute to disease development and progression.
STAT2: Much more than an antiviral protein
A protein known for guarding against viral infections leads a double life, new research shows, and can interfere with cell growth and the defense against parasites.
A protein makes the difference
It is well-established knowledge that blood vessels foster the growth of tumors.
Nuclear protein causes neuroblastoma to become more aggressive
Aggressive forms of neuroblastoma contain a specific protein in their cells' nuclei that is not found in the nuclei of more benign forms of the cancer, and the discovery, made through research from the University of Rochester Medical Center, could lead to new forms of targeted therapy.
How a protein could become the next big sweetener
High-fructose corn syrup and sugar are on the outs with calorie-wary consumers.
High animal protein intake associated with higher, plant protein with lower mortality rate
The largest study to examine the effects of different sources of dietary protein found that a high intake of proteins from animal sources -- particularly processed and unprocessed red meats -- was associated with a higher mortality rate, while a high intake of protein from plant sources was associated with a lower risk of death.
Protein in, ammonia out
A recent study has compiled and analyzed data from 25 previous studies.

Related Protein Reading:

The High-Protein Vegetarian Cookbook: Hearty Dishes that Even Carnivores Will Love
by Katie Parker (Author), Kristen Smith (Author)

The Effective Vegan Diet: 50 High Protein Recipes for a Healthier Lifestyle

The High-Protein Cookbook: More than 150 healthy and irresistibly good low-carb dishes that can be on the table in thirty minutes or less.
by Linda West Eckhardt (Author), Katherine West Defoyd (Author)

Janeva's Ideal Recipes: A Personal Recipe Collection for the Ideal Protein Phase 1 Diet [Revised Version 1]
by Janeva Caroline Eickhoff (Author)

Protein Power: The High-Protein/Low Carbohydrate Way to Lose Weight, Feel Fit, and Boost Your Health-in Just Weeks!
by Michael R. Eades (Author), Mary Dan Eades (Author)

The Ultimate Protein Powder Cookbook: Think Outside the Shake (New format and design)
by Anna Sward (Author)

Plant-Protein Recipes That You'll Love: Enjoy the goodness and deliciousness of 150+ healthy plant-protein recipes!
by Carina Wolff (Author)

The Oil-Protein Diet Cookbook
by Johanna Budwig (Author)

High-Protein Shakes: Strength-Building Recipes for Everyday Health
by Pamela Braun (Author)

Clean Protein: The Revolution that Will Reshape Your Body, Boost Your Energy—and Save Our Planet
by Kathy Freston (Author), Bruce Friedrich (Author)

Best Science Podcasts 2018

We have hand picked the best science podcasts for 2018. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Circular
We're told if the economy is growing, and if we keep producing, that's a good thing. But at what cost? This hour, TED speakers explore circular systems that regenerate and re-use what we already have. Guests include economist Kate Raworth, environmental activist Tristram Stuart, landscape architect Kate Orff, entrepreneur David Katz, and graphic designer Jessi Arrington.
Now Playing: Science for the People

#504 The Art of Logic
How can mathematics help us have better arguments? This week we spend the hour with "The Art of Logic in an Illogical World" author, mathematician Eugenia Cheng, as she makes her case that the logic of mathematics can combine with emotional resonance to allow us to have better debates and arguments. Along the way we learn a lot about rigorous logic using arguments you're probably having every day, while also learning a lot about our own underlying beliefs and assumptions.